Consun Pharmaceutical Group (HKG:1681) booked 498.3 million yuan in attributable profit in the first half of 2025, rising 25% from 399.8 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.
Earnings per share were 0.58 yuan, compared with 0.49 yuan in the prior year.
Revenue rose 24% year on year to 1.57 billion yuan, figures showed.
The company announced a dividend of HK$0.33 per share, payable Sept. 19 to shareholders of record on Sept. 5.